GSK's Walmsley Focused On Upcoming Launches Amid 'Uncertain' Times

 
• By Sukaina Virji

New CEO confirmed GSK's commitment to maintaining its three business unit structure ‒ "as long as all three businesses continue to perform competitively" ‒ as she chaired her first quarterly results presentation at the helm of the big pharma.

Emma Walmsley GSK
• Source: GSK

GlaxoSmithKline PLC's new CEO Emma Walmsley sees "both logic and benefit in being a three business healthcare company, not least because of some of the uncertainty and volatility that we still see in the high return pharma business," she said during the firm's first quarter earnings call April 26.

GSK's three units are pharmaceuticals, vaccines and consumer health. The company "believes in the synergies" between the business units, she...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

More from Business

China Signals Restarting IPOs For Unprofitable Biotechs

 
• By Dexter Jie Yan

The China Securities Regulatory Commission has proposed a new “growth tier” for the STAR Market of the Shanghai Stock Exchange, to reinstate the market’s listing standards for unprofitable firms.

BIO Notebook: Woodcock Calls For Doing The Right Thing, Dealmaking Remains Constrained

 
• By Mandy Jackson, Joseph Haas, and Sarah Karlin-Smith

Highlights from Day Four of the BIO International Convention include Woodcock offering practical advice on rare disease trials, the sorry state of dealmaking mid-year, Novartis discussing its approach to partnering, and Generate looking for funding to move into Phase III.

Syncona Looks To Go Private As Market Decline Deepens

 
• By Andrew McConaghie

While some are calling for Syncona to be wound up, the UK-based company believes many existing and new investors will back the creation of new private fund.